中德临床肿瘤学杂志(英文版)
中德臨床腫瘤學雜誌(英文版)
중덕림상종류학잡지(영문판)
THE CHINESE-GERMAN JOURNAL OF CLINICAL ONCOLOGY
2006年
2期
90-92
,共3页
刘端祺%刘慧龙%介雅慧%徐留柱
劉耑祺%劉慧龍%介雅慧%徐留柱
류단기%류혜룡%개아혜%서류주
激光%光动力学疗法%上消化道癌
激光%光動力學療法%上消化道癌
격광%광동역학요법%상소화도암
photodynamic therapy%upper gastrointestinal cancer
目的研究光动力学疗法治疗上消化道癌的近期疗效及毒副反应.方法临床各期上消化道癌患者56例,男性37例,女性19例,平均年龄65.6岁.应用630-PDT半导体激光器作为治疗光源,激光波长630nm,功率密度200~400mW/cm,能量密度100~300J/cm.光敏剂为PHOTOFRIN,按2mg/kg于照光前12~24h静脉滴注.结果完成治疗的56例患者中,完全效应6例(占10.7%),明显效应33例(占58.9%),稍有效应12例(占21.4%),无效5例(占8.9%).总有效率(CR+PR)为69.6%.所有病例均未出现严重毒副反应.结论光动力学疗法治疗临床各期上消化道癌疗效肯定,毒副反应轻,耐受性好,是一种较好的姑息治疗手段.
目的研究光動力學療法治療上消化道癌的近期療效及毒副反應.方法臨床各期上消化道癌患者56例,男性37例,女性19例,平均年齡65.6歲.應用630-PDT半導體激光器作為治療光源,激光波長630nm,功率密度200~400mW/cm,能量密度100~300J/cm.光敏劑為PHOTOFRIN,按2mg/kg于照光前12~24h靜脈滴註.結果完成治療的56例患者中,完全效應6例(佔10.7%),明顯效應33例(佔58.9%),稍有效應12例(佔21.4%),無效5例(佔8.9%).總有效率(CR+PR)為69.6%.所有病例均未齣現嚴重毒副反應.結論光動力學療法治療臨床各期上消化道癌療效肯定,毒副反應輕,耐受性好,是一種較好的姑息治療手段.
목적연구광동역학요법치료상소화도암적근기료효급독부반응.방법림상각기상소화도암환자56례,남성37례,녀성19례,평균년령65.6세.응용630-PDT반도체격광기작위치료광원,격광파장630nm,공솔밀도200~400mW/cm,능량밀도100~300J/cm.광민제위PHOTOFRIN,안2mg/kg우조광전12~24h정맥적주.결과완성치료적56례환자중,완전효응6례(점10.7%),명현효응33례(점58.9%),초유효응12례(점21.4%),무효5례(점8.9%).총유효솔(CR+PR)위69.6%.소유병례균미출현엄중독부반응.결론광동역학요법치료림상각기상소화도암료효긍정,독부반응경,내수성호,시일충교호적고식치료수단.
Objective: To evaluate the clinical effectiveness and adverse effects of photodynamic therapy (PDT) for the upper gastrointestinal tract cancers. Methods: 56 patients with upper gastrointestinal cancers in different clinical stages were treated with PDT. Diode laser (630 nm) was used as the light source and the parameters were as follows: power density 200 to 400 mW/cm, energy density 100 to 300 J/cm. PHOTOFRIN was used as photosensitizer, which was given in a dose of 2 mg/kg intravenously 12-24 h before irradiation. Results: Evaluation of the 56 patients' therapeutic effectiveness showed that 6 patients (10.7%) had a complete response (CR), 33 patients (58.9%) partial response (PR), 12 patients (21.4%) mild response (MR), and 5 patients (8.9%) no response (NR). The total response rate (CR+PR) was 69.6%. No patients had severe adverse effects in this group. Conclusion: PDT is an effective and safe palliative modality for upper gastrointestinal tract cancers.